Evidence map›Paper›PMID 35059151›Full record

ArticleChemical science2021

Metal substrate catalysis in the confined space for platinum drug delivery.

Susana Velasco-Lozano, Silvia Alonso-de Castro, Carlos Sanchez-Cano, Ana I Benítez-Mateos, Fernando López-Gallego, Luca Salassa

Abstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susana Velasco-LozanoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA) Paseo de Miramon 182 San Sebastián 20014 Spain flopez@cicbiomagune.es.ORCID https://orcid.org/0000-0001-9478-6750
Silvia Alonso-de CastroDonostia International Physics Center Paseo Manuel de Lardizabal 4 Donostia 20018 Spain lsalassa@dipc.org.ORCID https://orcid.org/0000-0001-5261-8839
Carlos Sanchez-CanoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA) Paseo de Miramon 182 San Sebastián 20014 Spain flopez@cicbiomagune.es.ORCID https://orcid.org/0000-0002-9522-0019
Ana I Benítez-MateosCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA) Paseo de Miramon 182 San Sebastián 20014 Spain flopez@cicbiomagune.es.ORCID https://orcid.org/0000-0001-6948-7652
Fernando López-GallegoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA) Paseo de Miramon 182 San Sebastián 20014 Spain flopez@cicbiomagune.es.ORCID https://orcid.org/0000-0003-0031-1880
Luca SalassaDonostia International Physics Center Paseo Manuel de Lardizabal 4 Donostia 20018 Spain lsalassa@dipc.org.ORCID https://orcid.org/0000-0002-2112-9095

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catalysis-based approaches for the activation of anticancer agents hold considerable promise. These principally rely on the use of metal catalysts capable of deprotecting inactive precursors of organic drugs or transforming key biomolecules available in the cellular environment. Nevertheless, the efficiency of most of the schemes described so far is rather low, limiting the benefits of catalytic amplification as strategy for controlling the therapeutic effects of anticancer compounds. In the work presented here, we show that flavin reactivity within a hydrogel matrix provides a viable solution for the efficient catalytic activation and delivery of cisplatin, a worldwide clinically-approved inorganic chemotherapy agent. This is achieved by ionically adsorbing a flavin catalyst and a Pt(iv) prodrug as substrate into porous amino-functionalized agarose beads. The hydrogel chassis supplies high local concentrations of electron donating groups/molecules in the surrounding of the catalyst, ultimately boosting substrate conversion rates (TOF >200 min

Identifiers

PMID35059151
PMCPMC8694326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.